Get the Stockscreener App
1.69
1.17%
-0.02
Synlogic Inc stock is traded at $1.69, with a volume of 51,127.
It is down -1.17% in the last 24 hours and up +1.32% over the past month.
Synlogic Inc is a biopharmaceutical company focuses on rare metabolic disorders, with a lead program in phenylketonuria (PKU) and homocystinuria (HCU). The company's pipeline includes therapeutics for enteric hyperoxaluria, gout, and cystinuria. Using a proprietary approach, the company engineer GI-restricted, oral medicines from well-characterized probiotics. These drug candidates target specific biological pathways, leveraging Escherichia coli Nissle 1917 for consistency and safety. Engineered to be non-colonizing and reversible, the company offer oral administration, simplifying shipping and storage. The company operates in one segment-discovery and development of Synthetic Biotics-pioneering transformative treatments for serious diseases.
See More
Previous Close:
$1.71
Open:
$1.67
24h Volume:
51,127
Relative Volume:
1.50
Market Cap:
$19.77M
Revenue:
$3.37M
Net Income/Loss:
$-57.28M
P/E Ratio:
-0.1572
EPS:
-10.7522
Net Cash Flow:
$-51.83M
1W Performance:
-4.52%
1M Performance:
+1.32%
6M Performance:
+48.25%
1Y Performance:
+17.36%
1-Day Range:
$1.67
$1.74
1-Week Range:
$1.67
$1.87
52-Week Range:
$0.898
$1.96
Synlogic Inc Stock (SYBX) Company Profile
Name
Synlogic Inc
Sector
Industry
Phone
617-659-2802
Address
PO BOX 30, WINCHESTER, MA
Compare SYBX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SYBX
Synlogic Inc
|
1.69 | 20.01M | 3.37M | -57.28M | -51.83M | -10.75 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 447.02M | -1.18B | -868.57M | -6.1812 |
Synlogic Inc Stock (SYBX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-24-21 | Upgrade | Oppenheimer | Perform → Outperform |
| Aug-21-19 | Downgrade | Oppenheimer | Outperform → Perform |
| Apr-30-19 | Initiated | Jefferies | Buy |
| Dec-13-18 | Initiated | Chardan Capital Markets | Buy |
| Mar-19-18 | Initiated | H.C. Wainwright | Buy |
| Jan-29-18 | Initiated | Piper Jaffray | Overweight |
View All
Synlogic Inc Stock (SYBX) Latest News
Why retail investors pile into Synlogic Inc. stockJuly 2025 Setups & AI Enhanced Trading Signals - newser.com
Is Synlogic Inc. stock entering bullish territoryDay Trade & AI Powered Market Trend Analysis - newser.com
How institutional buying supports Synlogic Inc. stockPortfolio Risk Report & Reliable Price Action Trade Plans - newser.com
Synlogic Inc. stock outlook for YEARWall Street Watch & Daily Oversold Bounce Ideas - newser.com
How Synlogic Inc. stock reacts to oil pricesTrade Signal Summary & Daily Profit Maximizing Tips - newser.com
Tick level data insight on Synlogic Inc. volatilityEarnings Growth Report & Stepwise Entry/Exit Trade Alerts - newser.com
How Synlogic Inc. stock benefits from tech adoptionM&A Rumor & Technical Pattern Based Signals - newser.com
Synlogic officer Dooley sells $284 in shares By Investing.com - Investing.com Australia
Synlogic officer Dooley sells $284 in shares - Investing.com
SYBX SEC FilingsSynlogic 10-K, 10-Q, 8-K Forms - Stock Titan
What Wall Street predicts for Synlogic Inc. stock priceWeekly Trend Recap & Smart Money Movement Tracker - newser.com
Can Synlogic Inc. stock sustain revenue growthPortfolio Performance Summary & Capital Protection Trading Alerts - newser.com
Will Synlogic Inc. stock outperform international peersJuly 2025 Breakouts & AI Driven Stock Price Forecasts - newser.com
Tools to monitor Synlogic Inc. recovery probability2025 Institutional Moves & Long-Term Safe Investment Ideas - newser.com
Will breakout in Synlogic Inc. lead to full recoveryWeekly Loss Report & Free Long-Term Investment Growth Plans - newser.com
Weiss Ratings Reaffirms “Sell (E+)” Rating for Synlogic (NASDAQ:SYBX) - Defense World
Synlogic Inc Stock (SYBX) Financials Data
Revenue
Net Income
Cash Flow
EPS
Synlogic Inc Stock (SYBX) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Dooley Mary Beth | See Remarks below |
Apr 02 '25 |
Sale |
1.20 |
144 |
173 |
12,901 |
| Dooley Mary Beth | See Remarks below |
Feb 03 '25 |
Sale |
1.33 |
2,107 |
2,802 |
13,045 |
1.62%
0.21%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):